Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow-up of Patients With Parkinson's Disease Who Had Administered of Allogenic Embryonic Stem Cell-derived A9 Dopamine Progenitor Cell (A9-DPC) in SB-PD-001 Study

NCT06477744 is registered in ClinicalTrials.gov with S.Biomedics Co., Ltd. as lead sponsor.

NCT NCT06477744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06477744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow-up of Patients With Parkinson's Disease Who Had Administered of Allogenic Embryonic Stem Cell-derived A9 Dopamine Progenitor Cell (A9-DPC) in SB-PD-001 Study
Lead sponsor
S.Biomedics Co., Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 14, 2023
Completion date
June 29, 2029
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease